Fifth Third Bancorp’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6M Buy
32,716
+23,504
+255% +$4.33M 0.01% 646
2025
Q4
$1.62M Buy
9,212
+202
+2% +$33K 0.01% 513
2025
Q3
$1.26M Buy
9,010
+1,633
+22% +$221K ﹤0.01% 570
2025
Q2
$926K Buy
7,377
+1,888
+34% +$235K ﹤0.01% 615
2025
Q1
$751K Buy
5,489
+2,243
+69% +$321K ﹤0.01% 653
2024
Q4
$496K Sell
3,246
-113
-3% -$19.1K ﹤0.01% 754
2024
Q3
$651K Sell
3,359
-177
-5% -$37K ﹤0.01% 709
2024
Q2
$820K Buy
3,536
+551
+18% +$120K ﹤0.01% 633
2024
Q1
$644K Sell
2,985
-135
-4% -$31.6K ﹤0.01% 694
2023
Q4
$807K Sell
3,120
-131
-4% -$32.2K ﹤0.01% 630
2023
Q3
$836K Sell
3,251
-704
-18% -$188K ﹤0.01% 614
2023
Q2
$1.13M Buy
3,955
+48
+1% +$14.3K 0.01% 552
2023
Q1
$1.09M Buy
3,907
+542
+16% +$150K 0.01% 551
2022
Q4
$932K Buy
3,365
+384
+13% +$108K ﹤0.01% 567
2022
Q3
$796K Sell
2,981
-77
-3% -$16.4K ﹤0.01% 592
2022
Q2
$624K Sell
3,058
-224
-7% -$45.8K ﹤0.01% 622
2022
Q1
$691K Sell
3,282
-6,002
-65% -$1.31M ﹤0.01% 640
2021
Q4
$2.23M Sell
9,284
-1,843
-17% -$474K 0.01% 452
2021
Q3
$3.15M Sell
11,127
-6,220
-36% -$2.04M 0.01% 397
2021
Q2
$6.01M Sell
17,347
-4,217
-20% -$1.28M 0.03% 323
2021
Q1
$6.03M Sell
21,564
-2,151
-9% -$580K 0.03% 320
2020
Q4
$5.81M Sell
23,715
-2,606
-10% -$672K 0.03% 312
2020
Q3
$7.47M Sell
26,321
-2,230
-8% -$622K 0.04% 270
2020
Q2
$7.64M Sell
28,551
-1,131
-4% -$340K 0.05% 265
2020
Q1
$9.39M Sell
29,682
-5,885
-17% -$1.79M 0.07% 199
2019
Q4
$10.6M Sell
35,567
-9,544
-21% -$2.65M 0.06% 230
2019
Q3
$10.5M Sell
45,111
-15,539
-26% -$3.62M 0.06% 224
2019
Q2
$14.2M Sell
60,650
-2,654
-4% -$613K 0.09% 178
2019
Q1
$15M Sell
63,304
-9,469
-13% -$2.98M 0.1% 173
2018
Q4
$21.9M Sell
72,773
-15,005
-17% -$4.79M 0.16% 135
2018
Q3
$31M Buy
87,778
+9,522
+12% +$3.28M 0.2% 121
2018
Q2
$22.7M Buy
78,256
+138
+0.2% +$38.8K 0.15% 143
2018
Q1
$21.4M Buy
78,118
+4,828
+7% +$1.5M 0.15% 143
2017
Q4
$23.3M Sell
73,290
-2,368
-3% -$760K 0.16% 137
2017
Q3
$23.7M Sell
75,658
-871
-1% -$258K 0.17% 134
2017
Q2
$20.8M Sell
76,529
-11,235
-13% -$2.97M 0.15% 141
2017
Q1
$24M Sell
87,764
-3,170
-3% -$896K 0.18% 131
2016
Q4
$25.8M Buy
90,934
+379
+0.4% +$112K 0.21% 121
2016
Q3
$28.3M Sell
90,555
-390
-0.4% -$116K 0.23% 116
2016
Q2
$22M Buy
90,945
+130
+0.1% +$34.3K 0.19% 134
2016
Q1
$23.6M Sell
90,815
-2,872
-3% -$759K 0.2% 126
2015
Q4
$28.7M Sell
93,687
-2,046
-2% -$588K 0.25% 108
2015
Q3
$27.9M Buy
95,733
+9,462
+11% +$3.12M 0.26% 109
2015
Q2
$34.8M Buy
86,271
+12,901
+18% +$5.18M 0.3% 98
2015
Q1
$31M Buy
73,370
+4,911
+7% +$1.94M 0.27% 105
2014
Q4
$23.2M Buy
68,459
+30,578
+81% +$9.89M 0.2% 127
2014
Q3
$12.5M Buy
37,881
+9,218
+32% +$3.04M 0.11% 168
2014
Q2
$9.04M Buy
28,663
+12,486
+77% +$3.76M 0.08% 215
2014
Q1
$4.95M Buy
16,177
+12,170
+304% +$3.86M 0.05% 299
2013
Q4
$1.12M Sell
4,007
-512
-11% -$132K 0.01% 565
2013
Q3
$1.09M Sell
4,519
-1,061
-19% -$237K 0.01% 565
2013
Q2
$1.2M Buy
+5,580
New +$1.19M 0.01% 547

Other funds holding BIIB

Fifth Third Bancorp's BIIB Position: Q1 2026 in Review

Fifth Third Bancorp increased its Biogen (BIIB) stake by 255% in Q1 2026, buying an estimated $4.33M and bringing the position to 32,716 shares worth $6M. The position accounts for 0.01% of the portfolio, ranked #646.

Fifth Third Bancorp first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.8M in Q2 2015. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Fifth Third Bancorp held 32,716 shares of Biogen worth $6M as of Q1 2026.
  • Fifth Third Bancorp bought 23,504 Biogen shares in Q1 2026, an estimated $4.33M.
  • Biogen made up 0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #646 holding.
  • Fifth Third Bancorp first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Fifth Third Bancorp's Biogen position peaked at $34.8M in Q2 2015.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.